Rua trims FY25 loss as revenue climbs and Czechia launch boosts EU push by Adam Sheldon September 2, 2025September 2, 2025 Rua Bioscience reported strong revenue growth and a narrowed loss for FY25 while marking a major […]
Cann Group halves FY25 loss as flower output climbs while oil falls by Adam Sheldon September 1, 2025September 1, 2025
ECS posts $5.7m loss as impairments overshadow record harvest and B2C growth by Adam Sheldon September 1, 2025September 1, 2025
Bioxyne swings to first significant profit on surging domestic sales by Adam Sheldon August 29, 2025August 29, 2025
News in brief: Losses widen for Avecho and Elixinol; InhaleRx secures HREC approval; Zelira cuts deficit; Argent shifts from ‘non-core’ activities by Adam Sheldon August 29, 2025February 21, 2026
Cannabis Council Australia to run free webinars on TGA review by Adam Sheldon August 29, 2025February 21, 2026
Montu calls for single prescriber framework in TGA submission by Adam Sheldon August 28, 2025August 28, 2025
News in brief: Wragg joins ANTG; Bioxyne launches legal claim; Epsilon appoints Kaplon by Martin Lane August 28, 2025February 21, 2026
Australia’s GMP mirage: why ‘EU-GMP equivalent’ fails the global cannabis test by Michael Sassano August 26, 2025August 26, 2025
